Astera Labs (NASDAQ:ALAB) Shares Up 9.2% – Time to Buy?

Astera Labs, Inc. (NASDAQ:ALAB)’s share price was up 9.2% on Monday . The company traded as high as $353.79 and last traded at $346.33. Approximately 5,024,784 shares traded hands during mid-day trading, a decline of 9% from the average daily volume of 5,542,213 shares. The stock had previously closed at $317.06.

Analyst Ratings Changes

Several research analysts have issued reports on the company. TD Cowen increased their price objective on Astera Labs from $140.00 to $225.00 and gave the stock a “hold” rating in a research report on Wednesday, May 6th. Citigroup downgraded shares of Astera Labs from a “buy” rating to a “market perform” rating in a report on Tuesday, May 26th. Weiss Ratings raised shares of Astera Labs from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, May 21st. Barclays boosted their price target on Astera Labs from $165.00 to $200.00 and gave the stock an “equal weight” rating in a research note on Thursday, May 7th. Finally, Northland Securities cut Astera Labs from an “outperform” rating to a “market perform” rating in a report on Tuesday, May 26th. Twelve investment analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $233.75.

Astera Labs Stock Performance

The business has a 50-day moving average of $212.95 and a 200 day moving average of $171.81. The stock has a market cap of $59.36 billion, a PE ratio of 234.01, a PEG ratio of 4.20 and a beta of 3.95.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share for the quarter, topping analysts’ consensus estimates of $0.54 by $0.07. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The company had revenue of $308.36 million for the quarter, compared to analyst estimates of $292.19 million. During the same quarter in the prior year, the company posted $0.33 EPS. The business’s revenue for the quarter was up 93.5% compared to the same quarter last year. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. Equities analysts expect that Astera Labs, Inc. will post 1.84 EPS for the current fiscal year.

Insider Buying and Selling at Astera Labs

In related news, COO Sanjay Gajendra sold 400,000 shares of the stock in a transaction on Thursday, May 21st. The stock was sold at an average price of $290.30, for a total value of $116,120,000.00. Following the transaction, the chief operating officer directly owned 5,064,213 shares of the company’s stock, valued at approximately $1,470,141,033.90. This trade represents a 7.32% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Manuel Alba sold 183,000 shares of the business’s stock in a transaction dated Wednesday, April 1st. The shares were sold at an average price of $107.61, for a total value of $19,692,630.00. Following the sale, the director directly owned 319,863 shares of the company’s stock, valued at approximately $34,420,457.43. This trade represents a 36.39% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 2,311,256 shares of company stock worth $477,341,446 in the last quarter. 10.40% of the stock is owned by insiders.

Institutional Trading of Astera Labs

A number of institutional investors and hedge funds have recently bought and sold shares of ALAB. Glenmede Trust Co. NA grew its stake in Astera Labs by 2.7% during the first quarter. Glenmede Trust Co. NA now owns 1,909 shares of the company’s stock worth $209,000 after buying an additional 51 shares during the period. Verus Capital Partners LLC lifted its holdings in shares of Astera Labs by 16.4% during the 1st quarter. Verus Capital Partners LLC now owns 3,849 shares of the company’s stock valued at $422,000 after acquiring an additional 541 shares in the last quarter. Liontrust Investment Partners LLP boosted its position in Astera Labs by 98.7% during the 1st quarter. Liontrust Investment Partners LLP now owns 105,270 shares of the company’s stock worth $11,538,000 after purchasing an additional 52,284 shares during the period. SOA Wealth Advisors LLC. acquired a new stake in Astera Labs in the 1st quarter valued at $49,000. Finally, E20 Capital Ltd purchased a new position in Astera Labs in the first quarter valued at about $33,310,000. Institutional investors and hedge funds own 60.47% of the company’s stock.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.